Closing

Do SGLT2 inhibitors improve kidney outcomes more than other treatments?

Mostly studied in type 2 & unspecified diabetes. Also asked versus placebo.

Not modeled yetTrial evidence exists, but no mechanistic model yetWithout a model there is no decisive experiment to propose. Help build it. →

Where the evidence stands

Doubtful. So far, the results disagree.

NoUnsureYes
Belief
0.23 (range 0.00–0.55)
Trials for
1
Trials against
3
Inconclusive
0

Already under way

The evidence so far

Registered trials
229
With posted results
41
Published papers
11

Of 43 decided analyses: 19 favor sglt2 inhibitors, 16 find no difference, 8 favor the comparator.

Papers

Trials

See every trial in the evidence map →